New antibody rationally designed for better tumor inhibition
Recently, Prof. XIE Can from the High Magnetic Field Laboratory of the Hefei Institutes of Physical Science (HFIPS), in a collaboration with Prof. YAN Xiyun's lab from the Institute of Biophysics, reported the structural basis of mAb AA98's inhibition on CD146-mediated endothelial cells (EC) activation and designed higher affinity monoclonal antibody HA98 for cancer treatment.
CD146 is an adhesion molecule that plays important roles in angiogenesis, cancer metastasis, and immune response. Prof. YAN Xiyun's lab has been focused on the function of CD146 and the mechanism ...
















